Back
Nektar Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
NKTR
Nektar Therapeutics
Last Price:
$44.55
Seasonality Move:
7.44%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Nektar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.23 | Sell |
| 20-day SMA: | 52.38 | Sell |
| 50-day SMA: | 56.38 | Sell |
| 200-day SMA: | 32.16 | Buy |
| 8-day EMA: | 46.15 | Sell |
| 20-day EMA: | 50.39 | Sell |
| 50-day EMA: | 52.79 | Sell |
| 200-day EMA: | 38.57 | Buy |
Nektar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.77 | Sell |
| Relative Strength Index (14 RSI): | 37.63 | Sell |
| Chaikin Money Flow: | 225519 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.02 - 60.32) | Sell |
| Bollinger Bands (100): | (36.87 - 62.57) | Sell |
Nektar Therapeutics Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Nektar Therapeutics Stock
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 44.49 while NKTR 8-day simple moving average is 45.23, which is a Sell signal.
-
The stock price of NKTR is 44.49 while Nektar Therapeutics 20-day SMA is 52.38, which makes it a Sell.
-
Nektar Therapeutics 50-day simple moving average is 56.38 while NKTR share price is 44.49, making it a Sell technically.
-
NKTR stock price is 44.49 and Nektar Therapeutics 200-day simple moving average is 32.16, creating a Buy signal.
NKTR Technical Analysis vs Fundamental Analysis
Sell
46
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy or a Sell?
-
Nektar Therapeutics stock is rated a SellThe current Nektar Therapeutics [NKTR] share price is $44.49. The Score for NKTR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Nektar Therapeutics Stock Info
Market Cap:
769.7M
Price in USD:
44.49
Share Volume:
406.3K
Nektar Therapeutics 52-Week Range
52-Week High:
66.92
52-Week Low:
6.48
Sell
46
Nektar Therapeutics (NKTR)
is a Sell
Nektar Therapeutics Share Price Forecast
-
What is the Nektar Therapeutics stock price today?The Nektar Therapeutics stock price is 44.49 USD today.
-
Will NKTR stock go up or go down?Nektar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Nektar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nektar Therapeutics is overvalued.
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 44.49 while NKTR 8-day exponential moving average is 46.15, which is a Sell signal.
-
The stock price of NKTR is 44.49 while Nektar Therapeutics 20-day EMA is 50.39, which makes it a Sell.
-
Nektar Therapeutics 50-day exponential moving average is 52.79 while NKTR share price is 44.49, making it a Sell technically.
-
NKTR stock price is 44.49 and Nektar Therapeutics 200-day simple moving average is 38.57, creating a Buy signal.
Fundamental Analysis of Nektar Therapeutics
Is Nektar Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.68 per share, and a decrease next year of $3.54 per share.
Technical Analysis of Nektar Therapeutics
Should I short Nektar Therapeutics stock?
-
NKTR Moving Average Covergence Divergence (MACD) indicator is -3.77, suggesting Nektar Therapeutics is a Sell
-
Nektar Therapeutics Relative Strength Index (RSI) is 37.63, which suggest Nektar Therapeutics is oversold
-
The Bollinger Bands (25) for Nektar Therapeutics is (47.02 - 60.32), which suggest Nektar Therapeutics is a Sell
-
The Bollinger Bands (100) for Nektar Therapeutics is (36.87 - 62.57), which suggest Nektar Therapeutics is a Sell
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.